Drug Information

Drug General Information
Drug ID
D08MNG
Former ID
DNC006864
Drug Name
C-(5-bromo-4,7-dimethoxyindan-1-yl)methylamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528433]
Structure
Download
2D MOL

3D MOL
Formula
C12H16BrNO2
Canonical SMILES
COC1=CC(=C(C2=C1C(CC2)CN)OC)Br
InChI
1S/C12H16BrNO2/c1-15-10-5-9(13)12(16-2)8-4-3-7(6-14)11(8)10/h5,7H,3-4,6,14H2,1-2H3
InChIKey
HCLPGYNQMVSQIM-UHFFFAOYSA-N
PubChem Compound ID
16086368
Target and Pathway
Target(s) 5-hydroxytryptamine 2A receptor Target Info Inhibitor [528433]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Serotonergic synapse
Inflammatory mediator regulation of TRP channels
PANTHER Pathway 5HT2 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (q) signalling events
WikiPathways Serotonin Receptor 2 and STAT3 Signaling
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
SIDS Susceptibility Pathways
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 528433J Med Chem. 2006 Sep 21;49(19):5794-803.1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.
Ref 528433J Med Chem. 2006 Sep 21;49(19):5794-803.1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.